InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sendrow Jerrold, Director. Director active across 1 companies, notably Virpax Pharmaceuticals, Inc.. In total, 3 reports have been logged. Total volume traded: €33k. The latest transaction was disclosed on 24 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€5,4074,500 shares@ €1.20150.18% mcap16.6% of flow
Common Stock, $0.00001 par value
SEC:0001493152-22-015224:0·
Ideal exit: 18 Feb 2023 (T+270)
€13,5763,900 shares@ €3.4809100.0% of flow
Common Stock, $0.00001 par value
SEC:0000905718-21-001536·
Ideal exit: 19 Aug 2022 (T+270)
€13,5763,900 shares@ €3.48090.44% mcap41.7% of flow
Common Stock, $0.00001 par value
SEC:0000905718-21-001536:0·
Ideal exit: 19 Aug 2022 (T+270)
3 of 3 declarations
About Sendrow Jerrold
Jerrold Sendrow is a Director at Virpax Pharmaceuticals, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Virpax Pharmaceuticals focuses on developing innovative treatments for serious diseases. Jerrold's experience in the pharmaceutical sector is valuable in guiding the company's direction.
